Published in Hepatitis Weekly, May 9th, 2005
"A liver biopsy is currently considered the definitive diagnostic modality for establishing the severity of hepatic fibrosis. We analyzed the diagnostic sensitivity and accuracy of ultrasound (US) using both low frequency and high frequency probes as a repeatable, inexpensive, and reliable method to determine the fibrosis stage in chronic liver disease and then compared our results with the histological findings," scientists writing in the British Journal of Radiology report.
"A total of 103 patients with chronic liver disease (60 males and 43 females, average age 51...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.